Literature DB >> 10792958

The efficacy of thyroidectomy for Graves' disease: A meta-analysis.

T K Palit1, C C Miller, D M Miltenburg.   

Abstract

BACKGROUND: Surgery for Graves' disease was largely replaced in the mid-1900s by radioiodine and antithyroid drugs, due to the belief that they were more safe and effective. Since then, thyroid surgery has improved with preoperative drug therapy and modern operative techniques. Recent clinical studies of thyroidectomy for Graves' disease may not reflect outcomes accurately because of small sample size, especially when estimating ideal thyroid remnant size. The purpose of this study was to combine modern clinical trials and use meta-analysis to determine the overall efficacy of both total (TT) and subtotal thyroidectomy (ST) for Graves' disease, compare thyroid function and complications rates of TT and ST, and determine ideal thyroid remnant size.
METHODS: Meta-analysis was performed on published studies in which patients underwent either TT or ST for Graves' disease. Meta-analysis was performed by weighted least-squares linear regression. P < 0.05 was considered significant.
RESULTS: There were 35 studies comprising 7241 patients. Mean follow-up was 5.6 years. Overall, persistent or recurrent hyperthyroidism occurred in 7.2% of patients. TT was performed on 538 patients and hypothyroidism occurred in all cases. ST was performed in 6703 patients, 59.7% of whom achieved euthyroidism, 25. 6% became hypothyroid, and 7.9% had either persistent or recurrent hyperthyroidism. Permanent recurrent laryngeal nerve injury occurred in 0.9% of TT patients and 0.7% of ST patients (P = NS). Permanent hypoparathyroidism occurred in 1.6% of TT patients and 1.0% of ST patients (P = NS). There was an 8.9% decrease in hypothyroidism and 6.9% increase in euthyroidism for each gram of thyroid remnant (P < 0.0001 each).
CONCLUSIONS: Overall, thyroidectomy successfully treated hyperthyroidism in 92% of patients with Graves' disease. There were no cases of hyperthyroidism following TT. ST achieved a euthyroid state in almost 60% of patients with an 8% rate of persistent or recurrent hyperthyroidism. There was no significant difference in complication rates between TT and ST. Copyright 2000 Academic Press.

Entities:  

Mesh:

Year:  2000        PMID: 10792958     DOI: 10.1006/jsre.2000.5875

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  51 in total

1.  Alternating from subtotal thyroid resection to total thyroidectomy in the treatment of Graves' disease prevents recurrences but increases the frequency of permanent hypoparathyroidism.

Authors:  Johannes Järhult; Per-Olof Andersson; Linda Duncker
Journal:  Langenbecks Arch Surg       Date:  2011-12-09       Impact factor: 3.445

2.  [Update hyperthyreoidism].

Authors:  L Möller; K Mann
Journal:  Internist (Berl)       Date:  2010-05       Impact factor: 0.743

3.  Evaluating meta-analyses in the general surgical literature: a critical appraisal.

Authors:  Elijah Dixon; Morad Hameed; Francis Sutherland; Deborah J Cook; Christopher Doig
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

Review 4.  Diagnosis and management of thyrotoxicosis.

Authors:  Elizabeth N Pearce
Journal:  BMJ       Date:  2006-06-10

Review 5.  Diagnosis and management of Graves disease: a global overview.

Authors:  Luigi Bartalena
Journal:  Nat Rev Endocrinol       Date:  2013-10-15       Impact factor: 43.330

6.  Comparative Effectiveness of Treatment Choices for Graves' Hyperthyroidism: A Historical Cohort Study.

Authors:  Vishnu Sundaresh; Juan P Brito; Prabin Thapa; Rebecca S Bahn; Marius N Stan
Journal:  Thyroid       Date:  2017-02-06       Impact factor: 6.568

Review 7.  Hyperthyroidism (primary).

Authors:  Birte Nygaard
Journal:  BMJ Clin Evid       Date:  2010-07-19

8.  Total thyroidectomy in Basedow-Graves' disease treatment: our experience.

Authors:  M Barbuscia; A Querci; A Tonante; D Paparo; F Taranto; A Ilacqua; E Gagliano; A Milone
Journal:  G Chir       Date:  2015 May-Jun

9.  Does thyroid surgery for Graves' disease improve health-related quality of life?

Authors:  Gregorio Scerrino; Giuditta Morfino; Nunzia Cinzia Paladino; Valentina Di Paola; Emanuele Amodio; Gaspare Gulotta; Sebastiano Bonventre
Journal:  Surg Today       Date:  2012-12-11       Impact factor: 2.549

10.  Current and emerging treatment options for Graves' hyperthyroidism.

Authors:  Prakash Abraham; Shamasunder Acharya
Journal:  Ther Clin Risk Manag       Date:  2010-02-02       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.